Cohance Lifesciences Limited has informed the Exchange about Schedule of meet
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cohance Lifesciences (formerly Suven Pharmaceuticals) has informed the stock exchanges that its management will attend the Investec CDMO Day roadshow in Hyderabad on March 13, 2026. The interaction will be in a group format, and the company has clarified that no unpublished price-sensitive information will be shared. The schedule remains subject to change due to exigencies on either side.
This is a routine compliance disclosure about an upcoming investor meet and carries no direct material impact on the stock. Investors may note the CDMO-focused engagement, which signals continued investor interest in the company's contract development and manufacturing business.